Here are the 424B prospectus supplements from International BAT MET (IBATF) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow IBATF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IBATF filings page.
International Battery Metals Ltd. is registering up to 51,530,518 common shares for resale, including 25,765,259 shares already issued and 25,765,259 shares issuable upon warrant exercise by a single selling shareholder. The company will not receive proceeds from shareholder sales but may receive cash if warrants are exercised.
The filing describes a pre-revenue, development-stage business built around a proprietary modular direct lithium extraction (MDLE) plant aimed at lithium brine owners. Management highlights early commercialization risk, a large accumulated deficit, the need for up to $10.0 million to customize its existing MDLE plant, and dependence on future capital raises.
Key risks include sharp lithium price volatility, uncertain demand tied to electric vehicles, intense competition from other DLE technologies, environmental and regulatory exposure, penny stock status, customer concentration risk, and identified material weakness in internal controls. The company is an emerging growth and smaller reporting company and uses reduced disclosure requirements.
International Battery Metals Ltd. is registering for resale up to 93,481,739 common shares and 39,219,779 warrants issued in prior private placements. The shares include previously issued stock and shares issuable upon warrant exercise, all to be sold by existing holders.
The company will not receive proceeds from shareholder resales but may receive cash if the 23/24 Warrants are exercised. Common shares trade on the TSXV as “IBAT” and OTCQB as “IBATF.” As of December 19, 2025, 316,573,123 common shares were outstanding.
The prospectus highlights that IBAT is a pre-revenue, development-stage lithium extraction technology company relying on its modular direct lithium extraction (MDLE) plants, faces significant commercialization, financing, regulatory and market risks, and qualifies as both an emerging growth company and a smaller reporting company under U.S. securities rules.